TriSalus Life Sciences Inc. (NASDAQ: TLSI)
$5.60
+0.0300 ( +0.54% ) 24.3K
TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.
Market Data
Open
$5.60
Previous close
$5.57
Volume
24.3K
Market cap
$202.07M
Day range
$5.53 - $5.68
52 week range
$3.32 - $16.24
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | May 07, 2024 |
8-k | 8K-related | 15 | Apr 30, 2024 |
8-k | 8K-related | 15 | Apr 16, 2024 |
10-k | Annual reports | 110 | Apr 11, 2024 |
nt | Quarterly Reports | 1 | Apr 02, 2024 |
8-k | 8K-related | 15 | Apr 01, 2024 |
8-k | 8K-related | 15 | Mar 12, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |